Risk factors and outcomes of early acute kidney injury in infective endocarditis: A retrospective cohort study.


Journal

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases
ISSN: 1878-3511
Titre abrégé: Int J Infect Dis
Pays: Canada
ID NLM: 9610933

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 20 04 2020
revised: 05 08 2020
accepted: 06 08 2020
pubmed: 17 8 2020
medline: 15 12 2020
entrez: 16 8 2020
Statut: ppublish

Résumé

The incidence of acute kidney injury (AKI) in infective endocarditis (IE), its risk factors and consequences on patient and renal survival remain debated. Patients hospitalized for a first episode of IE (possible or definite according to modified Duke criteria) between 2013 and 2016 were included. The primary endpoint was to determine risk factors for early AKI (E-AKI) during the first week of management of IE. A total of 276 patients were included: 220 (79.7%) had definite IE and 56 (20.3%) had possible IE. E-AKI occurred in 150 patients (53%). IE due to Staphylococcus aureus (OR 3.41; 95% CI 1.83-6.39; p<0.01), history of diabetes (OR 2.34; 95% CI 1.25-4.37; p<0.01), peripheral arterial disease (OR 2.59; 95% CI 1.07-6.23; p<0.05), immunological manifestations (OR 3.11; 95% CI 1.31-7.39; p=0.01), and use of norepinephrine (OR 3.44; 95% CI 1.72-7.02; p<0.01) were associated with E-AKI. In subgroup analysis, infectious disease consultation was associated with a lower risk of AKI at day 7 (OR 0.41; 95% CI 0.16-0.88; p=0.04). E-AKI was associated with 1-year mortality (OR 1.65; 95% CI 1.03-2.64; p=0.04) and chronic kidney disease progression (OR 2.23; 95% CI 1.30-3.82; p<0.01). E-AKI is common in IE and often associated with non-modifiable variables. Multidisciplinary management should be mandatory, and awareness of AKI diagnosis and etiological explorations should be raised.

Identifiants

pubmed: 32795604
pii: S1201-9712(20)30651-2
doi: 10.1016/j.ijid.2020.08.022
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

421-427

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Florent Von Tokarski (F)

Service de Médecine interne et Maladies Infectieuses, France; Service de Néphrologie-HTA, Dialyses, Transplantation Rénale, France.

Adrien Lemaignen (A)

Service de Médecine interne et Maladies Infectieuses, France. Electronic address: adrien.lemaignen@univ-tours.fr.

Antoine Portais (A)

Service de Médecine interne et Maladies Infectieuses, France.

Laurent Fauchier (L)

Service de Cardiologie, France.

Fanny Hennekinne (F)

Service de Gériatrie, France.

Bénédicte Sautenet (B)

Service de Néphrologie-HTA, Dialyses, Transplantation Rénale, France.

Jean-Michel Halimi (JM)

Service de Néphrologie-HTA, Dialyses, Transplantation Rénale, France.

Annick Legras (A)

Service de Médecine Intensive, France.

Frédéric Patat (F)

Service d'échographie, France.

Thierry Bourguignon (T)

Service de chirurgie cardio-vasculaire, France.

Christian Mirguet (C)

Service de réanimation cardio-vasculaire, CHRU de Tours, Tours, France.

Anne Bernard (A)

Service de Cardiologie, France.

Louis Bernard (L)

Service de Médecine interne et Maladies Infectieuses, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH